medigraphic.com
ISSN 1527-3172 (Digital)

2021, Número 3-4

<< Anterior Siguiente >>

MEDICC Review 2021; 23 (3-4)


Hypoxemia and Cytokine Storm in COVID-19: Clinical Implications

Machado-Curbelo C, González-Quevedo A

Idioma: Ingles.
Referencias bibliográficas: 44
Paginas: 54-59
Archivo PDF: 236.66 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Zhang DM, Chen SL. Cytokine storms causedby novel coronavirus 2019 and treatment for cardiacinjury. Eur Rev Med Pharmacol Sci. 2020Dec;24(23):12527–35.

  2. Mitchell WB. Thromboinfl ammation in COVID-19acute lung injury. Paediatr Respir Rev. 2020Sep;35:20–4. DOI: 10.1016/j.prrv.2020.06.004.Epub 2020 Jun 11.

  3. Lang M, Som A, Mendoza DP, Flores EJ,Reid N, Carey D, et al. Hypoxaemia related toCOVID-19: vascular and perfusion abnormalitieson dual-energy CT. Lancet Infect Dis. 2020Dec;20(12):1365–6. DOI: https://doi.org/10.1016/S1473-3099(20)30367-4

  4. Ministry of Public Health (CU). Protocolo deActuación Nacional para la COVID-19 (Versión1.6) 28 marzo 2021 [Internet]. Havana:Ministry of Public Health (CU); 2021 Mar 28[cited 2021 Apr 21]. Available at: https://fi les.sld.cu/editorhome/2021/2003/2028/ministerio-de-salud-publica-protocolo-de-actuacion-nacional-para-la-covid-2019-version-2021-2026-2028-marzo-2021. Spanish.

  5. Gautret P, Million M, Jarrot PA, Camoin-JauL, Colson P, Fenollar F, et al. Natural historyof COVID-19 and therapeutic options. ExpertRev Clin Immunol. 2020 Dec;16(12):1159–84.

  6. Teo JTR, Abidin NH, Cheah FC. Severe acuterespiratory syndrome-Coronavirus-2 infection:a review of the clinical pathological correlationsof Coronavirus disease-19 in children. Malays JPathol. 2020 Dec;42(3):349–61.

  7. Parasher A. COVID-19: Current understandingof its pathophysiology, clinical presentationand treatment. Postgrad Med J. 2021May;97(1147):312–20. DOI: 10.1136/postgradmedj-2020-138577

  8. Ackermann M, Verleden SE, Kuehnel M, HaverichA, Welte T, Laenger F, et al. Pulmonaryvascular endothelialitis, thrombosis, and angiogenesisin Covid-19. N Engl J Med. 2020 Jul 9;383(2):120–8.

  9. Saeed H, Osama H, Madney YM, Harb HS,Abdelrahman MA, Ehrhardt C, et al. COVID-19;current situation and recommended interventions.Int J Clin Pract [Internet]. 2020 Dec 5[cited 2021 Apr 20]. Available at: https://doi.org/10.1111/ijcp.13886. Epub ahead of print.

  10. Dhont S, Derom E, Van Braeckel E, Depuydt P,Lambrecht BN. The pathophysiology of ‘happy’hypoxemia in COVID-19. Respir Res [Internet].2020 Jul 28 [cited 2021 Apr 21];21(198). Availableat: https://doi.org/10.1186/s12931-020-01462-5

  11. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al.Clinical course and risk factors for mortality ofadult inpatients with COVID-19 in Wuhan, China:a retrospective cohort study. Lancet. 2020 Mar28;395(10229):1054–62.

  12. Kim P, Read S, Fauci A. Therapy for early COVID-19: a critical need. JAMA [Internet]. 2020 Dec1 [cited 2021 Apr 22];324(21):2149–50. Availableat: https://doi.org/10.1001/jama.2020.22813

  13. Jose RJ, Manuel A. COVID-19 cytokine storm:the interplay between infl ammation and coagulation.Lancet Respir Med. 2020 Jun;8(6):e46–e47.

  14. Tang L, Yin Z, Hu Y, Mei H. Controlling cytokinestorm is vital in COVID-19. Front Immunol [Internet].2020 Nov 30 [cited 2021 Apr 20];11:570993.Available at: https://www.frontiersin.org/articles/10.3389/fi mmu.2020.570993/full

  15. Jahani M, Dokaneheifard S, Mansouri K.Hypoxia: A key feature of COVID-19 launchingactivation of HIF-1 and cytokine storm. JInfl amm [Internet]. 2020 Oct 29 [cited 2021 Apr21];17(33). Available at: https://doi.org/10.1186/s12950-020-00263-3

  16. Signori D, Bellani G, Calcinati S, Grassi A,Patroniti N, Foti G. Effect of face mask designand bias fl ow on rebreathing during noninvasiveventilation. Respir Care. 2019 Jul;64(7):793–800.

  17. Jaber S, Bellani G, Blanch L, Demoule A, EstebanA, Gattinoni L, et al. The intensive care medicineresearch agenda for airways, invasive andnoninvasive mechanical ventilation. IntensiveCare Med. 2017 Sep;43(9):1352–65.

  18. Bellani G, Grasselli G, Cecconi M, Antolini L,Borelli M, De Giacomi F, et al. Noninvasive ventilatorysupport of COVID-19 patients outside theintensive care units (WARd-COVID). Ann AmThorac Soc [Internet]. 2021 Jan 4 [cited 2021Apr 21];18(6):1020–8. Available at: https://doi.org/10.1513/AnnalsATS.202008-1080OC

  19. De Virgiliis F, Di Giovanni S. Lung innervation inthe eye of a cytokine storm: neuroimmune interactionsand COVID-19. Nat Rev Neurol [Internet]. 2020 Nov [cited 2021 Apr 21];16(11):645–52.Available at: https://doi.org/10.1038/s41582-020-0402-y. Epub 2020 Aug 25.

  20. Serebrovska ZO, C hong EY, Serebrovska TV,Tumanovska LV. Hypoxia, HIF-1α, and COVID-19: from pathogenic factors to potential therapeutictargets. Acta Pharmacol Sin [Internet].2020 [cited 2021 Jul 21];41:1539–46. Availableat: https://doi.org/10.1038/s41401-020-00554-8

  21. Gozzo L, Viale P, Longo L, Vitale DC, DragoF. The potential role of heparin in patients withCOVID-19: beyond the anticoagulant effect. Areview. Front Pharmacol [Internet]. 2020 Aug 21[cited 2021 Apr 23];11:1307. Available at: https://doi.org/10.3389/fphar.2020.01307

  22. Jose RJ, Williams A, Manuel A, Brown JS,Chambers RC. Targeting coagulation activation in severe COVID-19 pneumonia: lessons frombacterial pneumonia and sepsis. Eur RespirRev [Internet]. 2020 Oct 1 [cited 2021 Apr21];29(157):200240. Available at: https://doi.org/10.1183/16000617.0240-2020

  23. Machado C. Early prevention of hypoxemia.2020 Nov 26. Comment on: Kim P, Read SW,Fauci AS. Therapy for early COVID-19: a criticalneed. JAMA [Internet]. 2020 Nov 2020 [cited2021 Apr 21]. Available at: https://doi.org/10.1001/jama.2020.22813

  24. Zhang R, Wu Y, Zhao M, Liu C, Zhou L, Shen S, etal. Role of HIF-1 alpha in the regulation ACE andACE2 expression in hypoxic human pulmonaryartery smooth muscle cells. Am J Physiol LungCell Mol Physiol. 2009 Oct;297(4):L631–40.

  25. Habashi NM, Camporota L, Gatto LA, NiemanG. Functional pathophysiology of SARS-CoV-2induced acute injury and clinical implications. JAppl Physiol. 2021 Mar 1;130(3):877−91. Availableat: https://doi.org/10.1152/japplphysiol.00742.2020

  26. Wang X, Tu Y, Huang B, Li Y, Li Y, Zhang S, et al.Pulmonary vascular endothelial injury and acutepulmonary hypertension caused by COVID-19:the fundamental cause of refractory hypoxemia?Cardiovasc Diagn Ther. 2020 Aug;10(4):892–7.

  27. Zhang J, Tecson KM, McCullough PA. Endothelialdysfunction contributes to COVID-19-associatedvascular infl ammation and coagulopathy. RevCardiovasc Med. 2020 Sep 30;21(3):315–19.

  28. Dandel M. Pathophysiology of COVID-19-associatedacute respiratory distress syndrome. LancetRespir Med [Internet]. 2021 Jan [cited 2021 Apr23];9(1):e4. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837097/

  29. Tan DX, Hardeland R. Targeting host defensesystem and rescuing compromised mitochondriato increase tolerance against pathogens by melatoninmay impact outcome of deadly virus infectionpertinent to COVID-19. Molecules [Internet].2020 Sep 25 [cited 2021 Apr 21];25(19):4410.Available at: https://doi.org/10.3390/molecules25194410

  30. Cellina M, Gibelli D, Valenti Pittino C, Toluian T,Marino P, Oliva G. Risk factors of fatal outcomein patients with COVID-19 pneumonia. DisasterMed Public Health Prep. 2020 Sep 10;1–8. DOI:10.1017/dmp.2020.346

  31. Alraddadi BM, Qushmaq I, Al-Hameed FM, MandourahY, Almekhlafi GA, Jose J, et al. Noninvasiveventilation in critically ill patients with theMiddle East respiratory syndrome. Infl uenzaOther Respir Viruses. 2019 Jul;13(4):382–90.

  32. Matthay MA, Thompson BT, Ware LB. The Berlindefi nition of acute respiratory distress syndrome:should patients receiving high-fl ow nasal oxygenbe included? Lancet Respir Med. 2021 Apr 26.DOI: 10.1016/S2213-2600(21)00105-3

  33. COVID-19 rapid guideline: Community-basedcare of patients with chronic obstructive pulmonarydisease (COPD) [Internet]. London:National Institute for Health and Care Excellence(UK); 2020 Apr 9 [cited 2021 Apr 21]. 13 p. Availableat: https://www.ncbi.nlm.nih.gov/books/NBK566605/pdf/Bookshelf_NBK566605.pdf

  34. Whittle JS, Pavlov I, Sacchetti AD, Atwood C,Rosenberg MS. Respiratory support for adultpatients with COVID-19. J Am Coll Emerg PhysiciansOpen. 2020 Apr;1(2):95–101. https://doi.org/10.1002/emp2.12071.

  35. Alqahtani JS, Mendes RG, Aldhahir A, RowleyD, AlAhmari MD, Ntoumenopoulos G, et al.Global current practices of ventilatory supportmanagement in COVID-19 patients: an internationalsurvey. J Multidiscip Healthc. 2020 Nov18;13:1635–48.

  36. Alviset S, Riller Q, Aboab J, Dilworth K, BillyPA, Lombardi Y, et al. Continuous Positive AirwayPressure (CPAP) face-mask ventilation isan easy and cheap option to manage a massiveinfl ux of patients presenting acute respiratoryfailure during the SARS-CoV-2 outbreak: aretrospective cohort study. PLoS One. 2020 Oct14;15(10):e0240645.

  37. Brusasco C, Corradi F, Di Domenico A, RaggiF, Timossi G, Santori G, et al. Continuous positiveairway pressure in Covid-19 patients withmoderate-to-severe respiratory failure. EurRespir J. 2021 Feb 17;57(2):2002524. DOI:10.1183/13993003.02524-2020

  38. Arina P, Baso B, Moro V, Patel H, Ambler G; UCLCritical Care COVID-19 Research Group. Discriminatingbetween CPAP success and failurein COVID-19 patients with severe respiratory failure.Intensive Care Med. 2021 Feb;47(2):237–9.

  39. Perkins GD, Couper K, Connolly B, Baillie JK,Bradley JM, Dark P, et al. RECOVERY- Respiratorysupport: respiratory strategies for patientswith suspected or proven COVID-19 respiratoryfailure; Continuous Positive Airway Pressure,High-fl ow Nasal Oxygen, and standard care:a structured summary of a study protocol for arandomised controlled trial. Trials [Internet]. 2020Jul 29 [cited 2021 Apr 23];21(1):687. Available at:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388424/

  40. Amirfarzan H, Cereda M, Gaulton TG, LeissnerKB, Cortegiani A, Schumann R, et al. Use ofHelmet CPAP in COVID-19 - A practical review.Pulmonology [Internet]. 2021 Feb 1 [cited 2021Apr 21]. Available at: https://doi.org/10.1016/j.pulmoe.2021.01.008

  41. Simonds AK, Hanak A, Chatwin M, Morrell MJ,Hall A, Parker KH, et al. Evaluation of dropletdispersion during non-invasive ventilation,oxygen therapy, nebuliser treatment and chestphysiotherapy in clinical practice: implications formanagement of pandemic infl uenza and otherairborne infections. Health Technol Assess. 2010Oct;14(46):131–72.

  42. Favero R, Volpato A, Francesco M, Fiore AD,Guazzo R, Favero L. Accuracy of 3D digital modelingof dental arches. Dental Press J Orthod.2019 Jan–Feb;24(1):38e31–37e37.

  43. Pons-Òdena M, Valls A, Grifols J, Farré R, CambraLasosa FJ, Rubin BK. COVID-19 and respiratorysupport devices. Paediatr Respir Rev.2020 Sep;35:61–3.

  44. Walker J, Dolly S, Ng L, Prior-Ong M, SabapathyK. The role of CPAP as a potential bridgeto invasive ventilation and as a ceiling-of-carefor patients hospitalized with Covid-19-Anobservational study. PLoS One. 2020 Dec31;15(12):e0244857. DOI: 10.1371/journal.pone.0244857




2020     |     www.medigraphic.com